In the presented study, we analyzed the influence of IVMP therapy on the circadian BP pattern, biochemical markers of heart failure (NT-proBNP), and myocardial injury (TnI), as well as the echocardiographic parameter (EF). The gene discussed is NPPB; the disease is heart failure.